1
|
van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Goldenberg NA, Holzhauer S, Monagle P, Nowak‐Göttl U, Revel‐Vilk S, Sciuccatie G, Sirachainan N, Male C. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost 2021; 19:1123-1129. [PMID: 33792176 PMCID: PMC8252713 DOI: 10.1111/jth.15260] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 01/28/2021] [Accepted: 02/01/2021] [Indexed: 01/16/2023]
Abstract
Pediatric thromboembolism is a rare and heterogenous disease. As a result, there is a paucity of knowledge with regard to natural history, management, and outcomes of most types of pediatric venous and arterial thromboembolism. International research collaboration is needed to fill these knowledge gaps. Not only randomized controlled trials, but also representative observational studies are required to answer all research questions. Therefore, the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis initiated the International Pediatric Thrombosis Network (IPTN). The aims of the IPTN include (1) development of the Throm-PED registry to facilitate international prospective observational studies, and (2) establishment of a network of pediatric thrombosis centers experienced in effectively conducting clinical trials and observational studies. The IPTN needs dedicated clinicians all over the world and several funding sources to obtain high-quality research data to reach its ultimate goal of improving care in children with thrombosis. The aim of this communication is to call for active participation in the IPTN to all physicians taking care of children with thrombosis worldwide.
Collapse
Affiliation(s)
- C. Heleen van Ommen
- Department of Pediatric Hematology‐OncologyErasmus MC Sophia Children's HospitalRotterdamthe Netherlands
| | - Manuela Albisetti
- Division of HematologyUniversity Children's HospitalZurichSwitzerland
| | - Mohir Bhatt
- Department of PediatricsMcMaster UniversityHamiltonOntarioCanada
| | - Marianne Bonduel
- Servicio de Hematología y OncologíaHospital de Pediatría Prof. Dr. Juan P. GarrahanBuenos AiresArgentina
| | - Brian Branchford
- Department of PediatricsUniversity of Colorado Anschutz Medical CampusDenverColoradoUSA
| | | | - Anthony Chan
- Department of PediatricsMcMaster UniversityHamiltonOntarioCanada
| | - Neil A. Goldenberg
- Departments of Pediatrics and MedicineDivision of HematologyJohns Hopkins University School of MedicineBaltimoreMarylandUSA
- Thrombosis and Stroke ProgramsJohns Hopkins All Children's Hospital, and Johns Hopkins All Children's Institute for Clinical and Translational ResearchSt. PetersburgFloridaUSA
| | | | - Paul Monagle
- Department of PediatricsHematology Research GroupMurdoch Children's Research InstituteThe University of MelbourneMelbourneAustralia
- Department of Clinical HematologyThe Royal Children's HospitalMelbourneAustralia
| | - Ulrike Nowak‐Göttl
- Department of Pediatric Hematology‐OncologyMünster and Institute of Clinical ChemistryUniversity Hospital Kiel‐LübeckUniversity of MünsterKielGermany
| | - Shoshana Revel‐Vilk
- Pediatric Hematology/Oncology UnitShaare‐Zedek Medical CenterHebrew UniversityJerusalemIsrael
| | - Gabriela Sciuccatie
- Servicio de Hematología y OncologíaHospital de Pediatría Prof. Dr. Juan P. GarrahanBuenos AiresArgentina
| | - Nongnuch Sirachainan
- Department of PediatricsFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand
| | - Christoph Male
- Department of PediatricsMedical University of ViennaViennaAustria
| | | |
Collapse
|
2
|
Recruitment Issues in Emerging Adult Populations: Focus on Adult Congenital Heart Disease. NURSING REPORTS 2020; 10:135-145. [PMID: 34968358 PMCID: PMC8608111 DOI: 10.3390/nursrep10020017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Revised: 11/26/2020] [Accepted: 11/26/2020] [Indexed: 11/21/2022] Open
Abstract
High-quality nursing research is important to healthcare and is precipitated by successful participant recruitment. Young adults aged 18 to 30 years are particularly difficult to recruit due to transitions during this time, which makes it more problematic to locate these individuals and may make it more difficult for them to prioritize the need for participation. This paper includes data from two cross-sectional survey design pilot studies that aimed to enroll young adults with congenital heart disease using a variety of recruitment methods. The number of participants enrolled in these two pilot studies (7 and 22) was much lower than expected but the recruitment challenges encountered were consistent with other research studies that have recruited young adult populations. After presenting these data and a discussion of the relevant literature, we conclude with proposed strategies for research recruitment of young adults for nurse scientists who directly impact evidence-based literature and practice with research contributions.
Collapse
|
3
|
McMullan J, Crowe AL, Bailie C, Moore K, McMullan LS, Shamandi N, McAneney H, McKnight AJ. Improvements needed to support people living and working with a rare disease in Northern Ireland: current rare disease support perceived as inadequate. Orphanet J Rare Dis 2020; 15:315. [PMID: 33168042 PMCID: PMC7649905 DOI: 10.1186/s13023-020-01559-6] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2020] [Accepted: 09/24/2020] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Many people living and working with rare diseases describe consistent difficulties accessing appropriate information and support. In this study an evaluation of the awareness of rare diseases, alongside related information and educational resources available for patients, their families and healthcare professionals, was conducted in 2018-2019 using an online survey and semi-structured interviews with rare disease collaborative groups (charities, voluntary and community groups) active across Northern Ireland (NI). METHODS This study had 2 stages. Stage 1 was an online survey and stage 2 involved semi-structured interviews both with rare disease collaborative groups in Northern Ireland. The surveys and interviews were used to locate existing resources as well as identify gaps where the development of further resources would be appropriate. RESULTS Ninety-nine rare disease collaborative groups engaged with the survey with 31 providing detailed answers. Resources such as information, communication, 'registries', online services, training and improvements to support services were queried. Excellent communication is an important factor in delivering good rare disease support. Training for health professionals was also highlighted as an essential element of improving support for those with a rare disease to ensure they approach people with these unique and challenging diseases in an appropriate way. Carers were mentioned several times throughout the study; it is often felt they are overlooked in rare disease research and more support should be in place for them. Current care/support for those with a rare disease was highlighted as inadequate. Nine semi-structured interviews were conducted with rare disease collaborative groups. Reoccurring themes included a need for more effective information and communication, training for health professionals, online presence, support for carers, and involvement in research. CONCLUSIONS All rare disease collaborative groups agreed that current services for people living and working with a rare disease are not adequate. An important finding to consider in future research within the rare disease field is the inclusion of carers perceptions and experiences in studies. This research provides insight into the support available for rare diseases across Northern Ireland, highlights unmet needs, and suggests approaches to improve rare disease support.
Collapse
Affiliation(s)
- Julie McMullan
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK.
| | - Ashleen L Crowe
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK
| | - Caitlin Bailie
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK
| | - Kerry Moore
- Northern Ireland Rare Disease Partnership, 2 William Street, Newtownards, BT23 4AH, UK
| | - Lauren S McMullan
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK
| | - Nahid Shamandi
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK
| | - Helen McAneney
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK
| | - Amy Jayne McKnight
- Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, Institute of Clinical Science, Block A, Grosvenor Road, Belfast, BT12 6BA, UK
| |
Collapse
|